Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

Qilu Hospital of Shandong University is the lead sponsor of 117 current clinical trials in our China register. 73 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Disitamab Vedotin, Iparomlimab and Tuvonralimab and Hydroxychloroquine. The most-studied condition is Stroke.

ClinicalTrials.gov trials by status

Recruiting7362%
Not yet open2925%
Active, closed119%
By invitation43%

Trials by phase

Not applicable4639%
Observational4337%
Phase 21513%
Phase 465%
Phase 133%
Phase EARLY_PHASE122%
Phase 2/311%
Phase 1/211%

Clinical trials sponsored by Qilu Hospital of Shandong University

117 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure NCT07275554 · ClinicalTrials.gov ↗ · HBV Related Acute-on-chronic Liver Failure, HBV-related Liver Cirrhosis, HBV (Hepatitis B Virus)	Observational	Recruiting	2024-12	China
Treatment Outcomes and Complications of Three Therapeutic Approaches for Concomitant Choledocholithiasis and Cholecystolithiasis NCT07413068 · ClinicalTrials.gov ↗ · Cholelithiasis Associated With Common Bile Duct Stones	Observational	Recruiting	2025-12	China
Wether VNS in Early Stage (3 Months) is Safe and More Beneficial for Post-stroke Motor Rehabilitation NCT06938243 · ClinicalTrials.gov ↗ · Stroke, Motor Rehabilitation	Phase 1	Recruiting	2025-05	China
Risk Factors, Prognosis, Clinicopathological and Metabolic Characteristics of EO- vs LO-PanNETs NCT07136701 · ClinicalTrials.gov ↗ · Pancreatic Neuroendocine Neoplasms (pNETs)	Observational	Recruiting	2025-08	China
Anti-reflux Mucosal Valvuloplasty Versus PPIs for GERD Treatment NCT06348420 · ClinicalTrials.gov ↗ · Gastroesophageal Reflux Disease	Not applicable	Recruiting	2024-09	China
A Prospective Birth Cohort of Infants With Allergy and Neurodevelopmental Disorders in China NCT06327906 · ClinicalTrials.gov ↗ · Child Allergy, Neurodevelopmental Disorders	Observational	Recruiting	2023-11	China
Risk Factors for Complications After Cranioplasty NCT06740773 · ClinicalTrials.gov ↗ · Cranioplasty, Postoperative Complications, Risk Assessment	Observational	Recruiting	2024-12	China
The Impact of Methylene Blue on the Quality of Recovery in Patients Undergoing Hemorrhoidectomy NCT06747195 · ClinicalTrials.gov ↗ · Hemorrhoidectomy, Postoperative Analgesia	Observational	Recruiting	2025-01	China
Application of AI Technology for the Diagnosis and Treatment of Geriatric Diseases NCT06295263 · ClinicalTrials.gov ↗ · Parkinson Disease, Alzheimer Disease, Nervous System Diseases	Observational	Recruiting	2022-03	China
A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology NCT06662071 · ClinicalTrials.gov ↗ · Bladder Cancer	Observational	Recruiting	2024-10	China
Target-directed Management of Cerebral Oxygenation in Patients After Receiving ECPR NCT06711016 · ClinicalTrials.gov ↗ · Cardiac Arrest	Not applicable	Recruiting	2025-04	China
Evaluating the Efficacy of Neoadjuvant Chemotherapy Drugs Based on Organoid Technology NCT07379281 · ClinicalTrials.gov ↗ · Bladder Cancer	Observational	Recruiting	2025-01	China
Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology. NCT07379268 · ClinicalTrials.gov ↗ · Bladder Cancer	Observational	Recruiting	2025-01	China
Observation of Iris Blood Flow Via OCTA in Diabetic Neovascular Glaucoma NCT07722910 · ClinicalTrials.gov ↗ · Neovascular Glaucoma, Type 2 Diabetes	Observational	Recruiting	2026-05	China
Multi-center Study on New Cardiovascular Remodeling and Function Parameters in Hypertension NCT05638503 · ClinicalTrials.gov ↗ · Hypertension	Observational	Recruiting	2022-05	China
Safety and Efficacy of Leucine-Restricted Diet Combined With Chemotherapy and Immunotherapy in Advanced Gastric Cancer NCT07537348 · ClinicalTrials.gov ↗ · Advanced Gastric Cancer	Phase 2	Recruiting	2026-01	China
MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients NCT06197724 · ClinicalTrials.gov ↗ · Non ST Segment Elevation Acute Coronary Syndrome	Observational	Recruiting	2024-01	China
Acupuncture for Postoperative Gastric Emptying Delay NCT07505927 · ClinicalTrials.gov ↗ · Gastroparesis Postoperative, Delayed Gastric Emptying Following Procedure	Not applicable	Recruiting	2026-04	China
Integrative Analysis of Exosome-Mediated Single-Cell Transcriptomics and Proteomics in Gastric Cardia Cancer NCT06702891 · ClinicalTrials.gov ↗ · Gastric Cardia Cancer	Observational	Recruiting	2024-12	China
An Intervention Study on Transcranial Photobiomodulation in Children With Attention Deficit Hyperactivity Disorder NCT06685601 · ClinicalTrials.gov ↗ · ADHD - Attention Deficit Disorder With Hyperactivity	Not applicable	Recruiting	2024-12	China
The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients NCT04728516 · ClinicalTrials.gov ↗ · Acute Coronary Syndrome, Helicobacter Pylori Infection Drugs: Amoxicillin, Pantoprazole	Phase 4	Recruiting	2023-04	China
High-Frequency Repetitive Transcranial Magnetic Stimulation for Cognitive Improvement in Patients With Post-Stroke Cognitive Impairment NCT07546877 · ClinicalTrials.gov ↗ · Post-Stroke Cognitive Impairment (PSCI), Repetitive Transcranial Magnetic Stimulation (rTMS), Stroke	Not applicable	Recruiting	2026-04	China
Effect of Urethral Balloon Dilatation on Urinary Retention After Spinal Cord Injury NCT06978205 · ClinicalTrials.gov ↗ · Spinal Cord Injuries (SCI), Urinary Bladder, Neurogenic, Urinary Retention	Not applicable	Recruiting	2025-04	China
An Artificial Intelligence System for Multimodal, Multi-class Diagnosing Solid Pancreatic Lesions Based on Endoscopic Ultrasound NCT07381192 · ClinicalTrials.gov ↗ · Endoscopic Ultrasound (EUS), Solid Pancreatic Lesion	Observational	Recruiting	2025-09	China
Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer NCT06656949 · ClinicalTrials.gov ↗ · Endometrial Cancer	Not applicable	Recruiting	2024-10	China
A Study on the Efficacy of Dual-Carrier-Frequency Transcranial Alternating Current Stimulation Modulating the Hippocampus for the Treatment of Chronic Non-Specific Low Back Pain NCT07832188 · ClinicalTrials.gov ↗ · Chronic Pain	Not applicable	Recruiting	2026-07	China
Colistin Methanesulfonate Sodium Inhalation for Prophylaxis of Ventilator-Associated Pneumonia (CIVAP): A Prospective, Multicentre, Double-Blind, Randomized, Placebo-Controlled Trial NCT06834971 · ClinicalTrials.gov ↗ · Ventilator-Associated Pneumonia (VAP) Drug: Colistimethate sodium	Not applicable	Recruiting	2025-07	China
Spironolactone Improved Children With Gene Mutations Related to NCOR NCT06678685 · ClinicalTrials.gov ↗ · NCOR Gene Mutations, Spironolactone, ASD	Phase 2/3	Recruiting	2024-10	China
Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC NCT07172685 · ClinicalTrials.gov ↗ · Prostate Cancer	Not applicable	Recruiting	2025-07	China
Phase II Trial of Iparomlimab/Tuvonralimab (QL1706) + XELOX in HER2-Negative, Low PD-L1 G/GEJ Adenocarcinoma NCT06932068 · ClinicalTrials.gov ↗ · HER2 Negative, Low PD-L1 Expressing, Unresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma Drug: Iparomlimab and Tuvonralimab	Phase 2	Recruiting	2025-03	China
Qishenyiqi Dripping Pill for Coronary Microvascular Disease NCT06699420 · ClinicalTrials.gov ↗ · Coronary Microvascular Disease	Phase 4	Recruiting	2023-11	China
Efficacy of an AI System in Training Endoscopists to Assess Gastric Intestinal Metaplasia Via the EGGIM Score NCT07208864 · ClinicalTrials.gov ↗ · Gastric Intestinal Metaplasia	Not applicable	Recruiting	2025-11	China
Prophylactic PS Placement to Prevent Pancreatitis After Endoscopic Transpapillary GPC for Cholelithiasis With Concomitant Choledocholithiasis NCT07495111 · ClinicalTrials.gov ↗ · Cholelithiasis Associated With Common Bile Duct Stones	Not applicable	Recruiting	2025-12	China
The Clinical Features and Pregnancy Outcomes of CTD Patients NCT04918524 · ClinicalTrials.gov ↗ · Connective Tissue Diseases, Pregnancy Related Drugs: Aspirin, Hydroxychloroquine, Prednisone	Observational	Recruiting	2018-09	China
Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology. NCT07379255 · ClinicalTrials.gov ↗ · Bladder Cancer	Observational	Recruiting	2025-01	China
Artificial Intelligence in Assessing Gastric Intestinal Metaplasia Via the EGGIM Score NCT07257796 · ClinicalTrials.gov ↗ · Intestinal Metaplasia of Gastric Mucosa, Artificial Intelligence, Endoscopy	Observational	Recruiting	2025-11	China
Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations NCT06041009 · ClinicalTrials.gov ↗ · Pancreatic Ductal Adenocarcinoma, Pancreatic Diseases, Pancreatic Elastase 1	Observational	Recruiting	2023-05	China
Neoadjuvant Therapy in Cervical Cancer NCT06558682 · ClinicalTrials.gov ↗ · Uterine Cervical Neoplasms	Not applicable	Recruiting	2024-10	China
Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer NCT06735326 · ClinicalTrials.gov ↗ · Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Drugs: Bevacizumab, Carboplatin, Fluzoparib	Phase 2	Recruiting	2024-11	China
Second-line Treatment of Metastatic Colorectal Cancer NCT06242067 · ClinicalTrials.gov ↗ · Metastatic Colorectal Cancer Drug: Trifluridine/Tipiracil	Phase 2	Recruiting	2023-04	China
Safety and Efficacy of Leucine-Restricted Diet Combined With Neoadjuvant Chemotherapy and Immunotherapy in Gastric Cancer NCT07537361 · ClinicalTrials.gov ↗ · Gastric Cancer, Leucine-restricted Diet	Phase 2	Recruiting	2026-01	China
Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS) NCT06092736 · ClinicalTrials.gov ↗ · Microvascular Angina	Phase 4	Recruiting	2018-12	China
Efficacy and Safety Analysis of Polylauric Alcohol More Stable Foam Versus Ordinary Foam in the Treatment of Head and Neck Venous Malformations NCT07066527 · ClinicalTrials.gov ↗ · Venous Malformation	Not applicable	Recruiting	2022-06	China
Exploring the Difference Between Gastric Cardia Cancer and Non-cardia Gastric Cancer Based on Multiomics NCT05812287 · ClinicalTrials.gov ↗ · Stomach Neoplasm	Observational	Recruiting	2024-03	China
Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites NCT06759064 · ClinicalTrials.gov ↗ · Cancer of Stomach, Adenocarcinoma, Ascites, Malignant Drug: Zoledronic Acid	Phase 1/2	Recruiting	2024-09	China
Tislelizumab Combined With Anlotinib and Nab-paclitaxel in III Resectable Non-small Cell Lung Cancer : A Prospective, Single-Arm, Phase II Study NCT07089199 · ClinicalTrials.gov ↗ · NSCLC, Tislelizumab, Anlotinib	Phase 2	Recruiting	2025-07	China
Cardiac Toxicity and Prognostic Value of New Echocardiographic Indicators in the Treatment of Primary Multiple Myeloma NCT06039735 · ClinicalTrials.gov ↗ · Multiple Myeloma	Observational	Recruiting	2023-11	China
Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis NCT07111572 · ClinicalTrials.gov ↗ · Ulcerative Colitis (UC), Fecal Calprotetin, FIT	Observational	Recruiting	2025-08	China
Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients NCT06704074 · ClinicalTrials.gov ↗ · Stroke	Not applicable	Recruiting	2026-05	China
DYNAMIC-UC: Early qFIT and Calprotectin Change Predicting Relapse in Biologic-Naive Ulcerative Colitis NCT07111273 · ClinicalTrials.gov ↗ · Ulcerative Colitis (UC), Fecal Calprotetin, FIT	Observational	Recruiting	2025-08	China
21-gene in Elder Breast Cancer Patients With Lymph Node Metastasis NCT06891651 · ClinicalTrials.gov ↗ · Breast Cancer Metastatic, Breast Cancer Survival	Observational	Recruiting	2024-12	China
Comparision of Endoscopic Discectomy and Microdiscectomy for the Treatment of Lumbar Spinal Stenosis NCT06719037 · ClinicalTrials.gov ↗ · Lumbar Spinal Stenosis	Not applicable	Recruiting	2024-12	China
Quinoa Improves Glycolipid Metabolism and Glucose Fluctuation Based on β-Cell Function in Early-stage Type 2 Diabetes NCT07329231 · ClinicalTrials.gov ↗ · Type 2 Diabetes Mellitus (T2DM)	Not applicable	Recruiting	2021-01	China
Use of Determine Learning-based Cardiodynamicsgram (CDG) for Rapid and Precise Stratification of Chest Pain in Emergency Department NCT06669884 · ClinicalTrials.gov ↗ · Chest Pain, Acute Coronary Syndrome	Observational	Recruiting	2021-10	China
Proteomics and Metabolomics of Body Fluid in Patients With Narcolepsy NCT06279247 · ClinicalTrials.gov ↗ · Narcolepsy	Observational	Recruiting	2022-09	China
The Clinical Efficacy of Immunomodulators in RA Patients NCT05626348 · ClinicalTrials.gov ↗ · Arthritis, Rheumatoid Drugs: Adalimumab, Hydroxychloroquine, Iguratimod	Phase 4	Recruiting	2021-12	China
Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection NCT06454578 · ClinicalTrials.gov ↗ · Carcinoma, Hepatocellular Drugs: Adebrelimab, Apatinib	Phase 2	Recruiting	2024-07	China
Cerebellar Deep Brain Stimulation or VNS for Chronic Post-stroke Motor Rehabilitation NCT06303960 · ClinicalTrials.gov ↗ · Stroke	Phase EARLY_PHASE1	Recruiting	2024-03	China
Effects of Different Modes of Action Observation Therapy on Swallowing Function After Stroke: a Study Based on fNIRS NCT07184892 · ClinicalTrials.gov ↗ · Stroke	Not applicable	Recruiting	2025-01	China
First-Line and Neoadjuvant Immunotherapy for Gastric Cancer NCT06727981 · ClinicalTrials.gov ↗ · Advanced Gastric Cancer, Locally Advanced Gastric Carcinoma Drug: Chemothearpy	Observational	Recruiting	2022-01	China
Clinical Application of Wearable Magnet Tracking System for Capsule Endoscopes NCT05546346 · ClinicalTrials.gov ↗ · Capsule Endoscopes	Not applicable	Recruiting	2023-03	China
Magnetocardiography in the Accurate Identification of Myocardial Infarction NCT05896826 · ClinicalTrials.gov ↗ · Chest Pain, Acute Coronary Syndrome, Myocardial Infarction	Observational	Recruiting	2023-06	China
Comparison of Double-tract and Tubular Gastric Anastomosis in Proximal Gastric Cancer NCT07635836 · ClinicalTrials.gov ↗ · Gastric Cancer (GC), Double-tract Reconstruction, Tubular Gastric Anastomosis	Not applicable	Recruiting	2026-05	China
MCG for Non-Obstructive Myocardial Ischemia NCT07657546 · ClinicalTrials.gov ↗ · Myocardial Ischemia	Observational	Recruiting	2025-04	China
Effect of Same-session EUS on ERCP in Pancreaticobiliary Diseases NCT06978231 · ClinicalTrials.gov ↗ · Pancreaticobiilary Diseases	Not applicable	Recruiting	2025-06	China
Treatment and Clinical Outcomes Among SLE Patients in Pregnancy NCT04976465 · ClinicalTrials.gov ↗ · Systemic Lupus Erythematosus, Pregnancy Related	Phase 1	Recruiting	2018-01	China
The Effect of Proton Pump Inhibitors(PPIs) on Endoscopic Treatment of Walled-off Necrosis (WON) NCT07488299 · ClinicalTrials.gov ↗ · Pancreatic Walled-off Necrosis	Not applicable	Recruiting	2025-09	China
First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2) NCT06730373 · ClinicalTrials.gov ↗ · HER2-positive Gastric Cancer, Metastatic Gastric Cancer, Unresectable Gastric Carcinoma Drugs: Capecitabine, Cisplatin, Disitamab Vedotin	Phase 2	Recruiting	2024-10	China
An Artificial Intelligence System for Multimodal, Multi-class Diagnosis of Pancreatic Cystic Lesions Based on Endoscopic Ultrasonography NCT07543263 · ClinicalTrials.gov ↗ · Pancreatic Cystic Lesion (PCL)	Observational	Recruiting	2026-04	China
A Single-arm Clinical Trial Using Patient-derived Tumor Tissue Fragment Models for Drug Sensitivity Testing to Guide Treatment in Previously Treated Cancers NCT07264803 · ClinicalTrials.gov ↗ · Solid Tumor Malignancies, Solid Tumor Cancer	Phase 2	Recruiting	2024-03	China
Efficacy and Safety of Apantamide Combined With Docetaxel and ADT vs. Apantamide Combined With ADT in Patients With High Tumor Burden mHSPC: a Multicenter and Prospective Cohort Study NCT05713578 · ClinicalTrials.gov ↗ · Cohort Studies	Phase EARLY_PHASE1	Recruiting	2023-03	China
An Artificial Intelligence System for ROSE of EUS-FNA Sample: a Prospective, Multicenter, Diagnostic Study. NCT06718725 · ClinicalTrials.gov ↗ · The Malignant Lesions and Non-malignant Lesions of Pancreas, Bile Duct, Liver and Lymph Node	Observational	Recruiting	2024-09	China
Brain Network Characteristics of Pain Patients Based on Magnetoencephalography NCT07809542 · ClinicalTrials.gov ↗ · Muscle Pain	Observational	Recruiting	2026-05	China
A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors NCT06300216 · Neuroendocrine Tumors	Observational	Not yet open	2024-03	China
IABP for MI-VSD Patients in SCAI SHOCK Stage B NCT07267884 · ClinicalTrials.gov ↗ · Acute Myocardial Infarction (AMI), Ventricular Septal Defects (VSD)	Not applicable	Not yet open	2026-02	China
Cardiovascular Ultrasound for the Rehabilitation of Patients With Coronary Heart Disease After PCI NCT06640400 · ClinicalTrials.gov ↗ · Coronary Heart Disease	Not applicable	Not yet open	2024-10	China
Evaluation of the Efficacy and Safety of Indocyanine Green Tracing in 3D Fluorescent Laparoscopic Lymph Node Dissection for Gastric Cancer NCT06421220 · ClinicalTrials.gov ↗ · Gastric Cancer	Not applicable	Not yet open	2024-05	China
Antarctic Krill Oil Functional Food Mitigates Bladder Cancer Treatment Side Effects NCT06880939 · ClinicalTrials.gov ↗ · Urinary Bladder Neoplasms	Not applicable	Not yet open	2025-07	China
Vericiguat for Heart Failure With Reduced Ejection Fraction After Myocardial Infarction NCT06717204 · ClinicalTrials.gov ↗ · HFrEF - Heart Failure With Reduced Ejection Fraction, Myocardial Infarction (MI) Drug: Vericiguat	Observational	Not yet open	2025-01	China
A Prospective, Multicenter, Observational Study of the Safety and Efficacy of Emergency Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis NCT07108478 · ClinicalTrials.gov ↗ · Severe Aortic Valve Stenosis	Observational	Not yet open	2025-07	China
Cost Profile and Budget Implications of Rechargeable Versus Non-rechargeable Sacral Neuromodulation Devices for Neurogenic Lower Urinary Tract Dysfunction NCT07173517 · ClinicalTrials.gov ↗ · Rechargeable Sacral Neuromodulation Device, Neurogenic Lower Urinary Tract Dysfunction	Observational	Not yet open	2025-10	China
The Efficacy and Safety RC48 Plus QL1706 in Second-Line Treatment of HER2-Expressing Recurrent CC NCT07172217 · ClinicalTrials.gov ↗ · Recurrent Cervical Cancer Drugs: Disitamab Vedotin, Iparomlimab and Tuvonralimab	Phase 2	Not yet open	2025-10	China
Effects of Individualized iTBS on Upper Limb Function After Stroke NCT06147167 · ClinicalTrials.gov ↗ · Upper Extremity Paresis, Stroke	Not applicable	Not yet open	2024-05	China
A Novel Wearable Transcutaneous Tibial Nerve Stimulation (TTNS) Device in the Treatment of Patients With Overactive Bladder (OAB) and Nocturia NCT07635251 · ClinicalTrials.gov ↗ · Overactive Bladder (OAB), Nocturia	Not applicable	Not yet open	2026-06	China
Bilateral Comparison of Unilateral Sacral Neuromodulation Test Stimulation in the Treatment of Neurogenic Bladder NCT07505940 · ClinicalTrials.gov ↗ · Neurogenic Bladder	Not applicable	Not yet open	2026-03	China
Efficacy of Probiotics for OAB Patients With Anxiety NCT07635212 · ClinicalTrials.gov ↗ · Overactive Bladder (OAB)	Not applicable	Not yet open	2026-07	China
Prophylactic IABP in Delayed-Presentation Anterior STEMI NCT07761455 · ClinicalTrials.gov ↗ · Acute Anterior ST-Segment Elevation Myocardial Infarction	Not applicable	Not yet open	2026-08	China
EUS-guided Embolization of the Visceral Artery Aneurysm NCT07490678 · ClinicalTrials.gov ↗ · Aneurysm	Not applicable	Not yet open	2026-03	China
Intraoperative Longitude-Latitude-Depth Localization Versus Preoperative CT-Guided Percutaneous Lung Puncture Localization for 0.8-2 cm Peripheral Pulmonary Nodules NCT07675889 · ClinicalTrials.gov ↗ · Pulmonary Nodule, Solitary, Peripheral Pulmonary Nodules, Pulmonary Nodules	Not applicable	Not yet open	2026-07	China
QL1706 Plus XELOX as Neoadjuvant Therapy for MSS/pMMR Clinical Stage III Colon Cancer NCT07156682 · ClinicalTrials.gov ↗ · Colon Cancer, MSS/pMMR, QL1706 Drugs: Iparomlimab and Tuvonralimab, Xelox	Phase 2	Not yet open	2025-09	China
Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma NCT07500831 · ClinicalTrials.gov ↗ · Carcinoma, Renal Cell, Metastatic Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Drugs: Axitinib, Toripalimab	Not applicable	Not yet open	2026-04	China
Transcutaneous Tibial Nerve Stimulation (TTNS) Patch in the Treatment of Patients With Lower Urinary Tract Symptoms (LUTS) After Benign Prostatic Hyperplasia (BPH) Surgery NCT07710794 · ClinicalTrials.gov ↗ · Lower Urinary Tract Symptoms (LUTS), BPH (Benign Prostatic Hyperplasia)	Not applicable	Not yet open	2026-06	China
EECP for Erectile Dysfunction in Elderly Hypertensive Patients NCT07831551 · ClinicalTrials.gov ↗ · Hypertension, Erectile Dysfunction	Not applicable	Not yet open	2026-10	China
Qishenyiqi for Ventricular Remodeling After Myocardial Infarction NCT06699407 · ClinicalTrials.gov ↗ · Chronic Stable Heart Failure	Phase 4	Not yet open	2024-11	China
Comparison of the GMA-TULIP and I-gel Laryngeal Mask for Airway Management in General Anaesthesia: a Randomized Controlled Trial NCT07019961 · ClinicalTrials.gov ↗ · Trauma Surgery, General Anesthesia	Not applicable	Not yet open	2025-07	China
Compound Danshen Dripping Pill for Diabetic Microvascular Angina NCT06727890 · ClinicalTrials.gov ↗ · Diabetic Microvascular Angina	Phase 4	Not yet open	2025-01	China
Virtual Reality's Impact on Upper Limb Function in Post-stroke Patients NCT06881680 · ClinicalTrials.gov ↗ · Stroke	Not applicable	Not yet open	2025-03	China
Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer. NCT06500247 · ClinicalTrials.gov ↗ · The Efficacy of Abiraterone Acetate Combined With Dalpicilib in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer Drugs: Abiraterone acetate, Dalpicilib, Prednisone	Phase 2	Not yet open	2024-07	China
Coronary Computed Tomographic Angiography Combined With CT-FFR in Intermediate-Risk Chest Pain Patients. NCT07140419 · ClinicalTrials.gov ↗ · Chest Pain, Coronary Artery Disease, Emergency Department	Not applicable	Not yet open	2026-04	China
Chemoradiotherapy Sequenced Radical Surgery for Colorectal Cancer With PALNM NCT05129774 · ClinicalTrials.gov ↗ · Colorectal Neoplasms Malignant, Lymph Node Excision, Chemoradiotherapy	Not applicable	Not yet open	2022-01	China

Showing the 100 most recently updated of 117 trials (recruiting first). The rest are in the country registers linked in each row.

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Qilu Hospital of Shandong University trials

40 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Conditions in Qilu Hospital of Shandong University trials

168 conditions

Stroke7 Bladder Cancer4 Gastric Cancer (GC)3 Gastric Cancer3 Acute Coronary Syndrome3Chest Pain3Stage II-III Gastric Cancer2HBV Related Acute-on-chronic Liver Failure2Cholelithiasis Associated With Common Bile Duct Stones2Hypertension2 Advanced Gastric Cancer2Overactive Bladder (OAB)2Pregnancy Related2 HER2-positive Gastric Cancer2 Ulcerative Colitis (UC)2Fecal Calprotetin2FIT2Neuroendocrine Tumors1Advanced Gastric or Gastroesophageal Junction Adenocarcinoma1HBV-related Liver Cirrhosis1HBV (Hepatitis B Virus)1Acute Myocardial Infarction (AMI)1Ventricular Septal Defects (VSD)1Knee Arthroplasty, Total1

By trial register

Register	Trials	Recruiting
Clinical trials in China	117	73

A trial with sites in more than one country appears in each of those registers; recruiting counts cover the trials listed on this page.

Other sponsors in Stroke

Sponsor	Trials
Xuanwu Hospital, Beijing	8
Shanghai East Hospital	3
Magnetic Tides	2
The Second Hospital of Anhui Medical University	2
The Hong Kong Polytechnic University	2
The Second Affiliated Hospital of Kunming Medical University	2
Duke Kunshan University	2
Occlutech International	1
Shanghai MicroPort Medical (Group)	1
Christian Medical College and Hospital, Ludhiana, India	1

Sponsors with the most current trials registered for this condition.

Questions about Qilu Hospital of Shandong University trials

How many clinical trials does Qilu Hospital of Shandong University sponsor?

Qilu Hospital of Shandong University is the lead sponsor of 117 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Qilu Hospital of Shandong University trials recruiting?

Yes. 73 of its 117 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Qilu Hospital of Shandong University testing?

Its current trials name 40 drugs and biologicals as interventions. The most frequent are Disitamab Vedotin (3), Iparomlimab and Tuvonralimab (3), Hydroxychloroquine (2), Prednisone (2) and Tislelizumab (2). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Qilu Hospital of Shandong University clinical trials